355 related articles for article (PubMed ID: 19496827)
1. Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands.
Liu QR; Pan CH; Hishimoto A; Li CY; Xi ZX; Llorente-Berzal A; Viveros MP; Ishiguro H; Arinami T; Onaivi ES; Uhl GR
Genes Brain Behav; 2009 Jul; 8(5):519-30. PubMed ID: 19496827
[TBL] [Abstract][Full Text] [Related]
2. CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity.
Onaivi ES; Ishiguro H; Gu S; Liu QR
J Psychopharmacol; 2012 Jan; 26(1):92-103. PubMed ID: 21447538
[TBL] [Abstract][Full Text] [Related]
3. Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer.
Qamri Z; Preet A; Nasser MW; Bass CE; Leone G; Barsky SH; Ganju RK
Mol Cancer Ther; 2009 Nov; 8(11):3117-29. PubMed ID: 19887554
[TBL] [Abstract][Full Text] [Related]
4. Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations.
Mulè F; Amato A; Baldassano S; Serio R
Pharmacol Res; 2007 Sep; 56(3):185-92. PubMed ID: 17656103
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system.
Schatz AR; Lee M; Condie RB; Pulaski JT; Kaminski NE
Toxicol Appl Pharmacol; 1997 Feb; 142(2):278-87. PubMed ID: 9070350
[TBL] [Abstract][Full Text] [Related]
6. Commentary: Functional Neuronal CB2 Cannabinoid Receptors in the CNS.
Onaivi ES
Curr Neuropharmacol; 2011 Mar; 9(1):205-8. PubMed ID: 21886591
[TBL] [Abstract][Full Text] [Related]
7. Behavioral effects of CB2 cannabinoid receptor activation and its influence on food and alcohol consumption.
Onaivi ES; Carpio O; Ishiguro H; Schanz N; Uhl GR; Benno R
Ann N Y Acad Sci; 2008 Oct; 1139():426-33. PubMed ID: 18991890
[TBL] [Abstract][Full Text] [Related]
8. Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro.
Thomas A; Baillie GL; Phillips AM; Razdan RK; Ross RA; Pertwee RG
Br J Pharmacol; 2007 Mar; 150(5):613-23. PubMed ID: 17245363
[TBL] [Abstract][Full Text] [Related]
9. Low Basal CB2R in Dopamine Neurons and Microglia Influences Cannabinoid Tetrad Effects.
Liu QR; Canseco-Alba A; Liang Y; Ishiguro H; Onaivi ES
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33371336
[TBL] [Abstract][Full Text] [Related]
10. Involvement of the CB
Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
[TBL] [Abstract][Full Text] [Related]
11. Cloning and pharmacological characterization of the dog cannabinoid CB₂receptor.
Ndong C; O'Donnell D; Ahmad S; Groblewski T
Eur J Pharmacol; 2011 Nov; 669(1-3):24-31. PubMed ID: 21871882
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid receptors are widely expressed in goldfish: molecular cloning of a CB2-like receptor and evaluation of CB1 and CB2 mRNA expression profiles in different organs.
Cottone E; Pomatto V; Cerri F; Campantico E; Mackie K; Delpero M; Guastalla A; Dati C; Bovolin P; Franzoni MF
Fish Physiol Biochem; 2013 Oct; 39(5):1287-96. PubMed ID: 23504102
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors.
Accorsi-Mendonça D; Almado CE; Dagostin AL; Machado BH; Leão RM
Brain Res; 2008 Mar; 1200():1-9. PubMed ID: 18308297
[TBL] [Abstract][Full Text] [Related]
14. Progress in brain cannabinoid CB
Jordan CJ; Xi ZX
Neurosci Biobehav Rev; 2019 Mar; 98():208-220. PubMed ID: 30611802
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Fas receptor/Fas-associated protein with death domain apoptotic complex and associated signalling systems by cannabinoid receptors in the mouse brain.
Alvaro-Bartolomé M; Esteban S; García-Gutiérrez MS; Manzanares J; Valverde O; García-Sevilla JA
Br J Pharmacol; 2010 Jun; 160(3):643-56. PubMed ID: 20590568
[TBL] [Abstract][Full Text] [Related]
16. Evidence for a modulatory role of cannabinoids on the excitatory NANC neurotransmission in mouse colon.
Mulè F; Amato A; Baldassano S; Serio R
Pharmacol Res; 2007 Aug; 56(2):132-9. PubMed ID: 17574859
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists.
Ashton JC; Wright JL; McPartland JM; Tyndall JD
Curr Med Chem; 2008; 15(14):1428-43. PubMed ID: 18537620
[TBL] [Abstract][Full Text] [Related]
18. The CB1/CB2 receptor agonist WIN-55,212-2 reduces viability of human Kaposi's sarcoma cells in vitro.
Luca T; Di Benedetto G; Scuderi MR; Palumbo M; Clementi S; Bernardini R; Cantarella G
Eur J Pharmacol; 2009 Aug; 616(1-3):16-21. PubMed ID: 19539619
[TBL] [Abstract][Full Text] [Related]
19. Species comparison and pharmacological characterization of rat and human CB2 cannabinoid receptors.
Mukherjee S; Adams M; Whiteaker K; Daza A; Kage K; Cassar S; Meyer M; Yao BB
Eur J Pharmacol; 2004 Nov; 505(1-3):1-9. PubMed ID: 15556131
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of a novel cannabinoid ligand, MDA19, for treatment of neuropathic pain.
Xu JJ; Diaz P; Astruc-Diaz F; Craig S; Munoz E; Naguib M
Anesth Analg; 2010 Jul; 111(1):99-109. PubMed ID: 20522703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]